🔗 Visit the ClinicalTrials.gov page for NCT02258204
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. | Nat Med | 2001 | 5.28 |
| 2 | Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation. | Stroke | 2011 | 0.87 |